|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Patento numeris | 3400239 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17736478.3 |
| Europos patento paraiškos padavimo data | 2017-01-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/012621 |
| Data | 2017-01-06 |
| (87) | Numeris | WO 2017/120534 |
| Data | 2017-07-13 |
| (30) | Numeris | Data | Šalis |
| 201662276806 P | 2016-01-08 | US |
| (72) |
LIN, Rong-Hwa , US
LIN, Shih-Yao , TW
TSAI, Yu-Ying , TW
|
| (73) |
AltruBio Inc. ,
1209 Orange Street, Wilmington, New Castle County, DE 19801,
US
|
| (54) | TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF |
| TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF |